Novartis continues its investments in Lek, a Sandoz company. To date, Novartis invested more than 2 billion Euros, half of which was invested in the development and the other half in modernization and expansion of production capabilities.
Novartis is the leading provider of medicines in Slovenia operating through Lek, Novartis Pharma Services and Sandoz. Together we build and maintain our reputation as a dynamic, ethical and trusted pharmaceutical company.
Lek, a Sandoz company, has been co-creating development trends in the global pharmaceutical industry for 70 years and has been continuously growing. We are a Slovenian, European and global pharmaceutical generic company, people-orientated and future-oriented. With our knowledge, quality and experience we have become one of the key parts of Sandoz.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR
Visit the pharmaceutical collection, Slovenian national cultural heritage.